Drawing for STUART THERAPEUTICS

USPTO serial 88098792

STUART THERAPEUTICS

Reviewed by CopyMark Law Group

Reg. 6739684Status 700Registered
Filing date
Status date
Registration date
May 24, 2022
Examiner
MEYERS, MORGAN LAURA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with STUART THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey K. Mills

Jeffrey K. Mills MEDLER FERRO WOODHOUSE & MILLS PLLC8201 GREENSBORO DRIVE, SUITE 1060MCLEAN, VA 22102UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Amino acids for medical or veterinary purposes; Amino acids for medical purposes; Amino acids for veterinary purposes; Anaesthetics; Analgesics; Biological preparations for the treatment of cancer; Biological preparations for the treatment of ocular disorders or diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for ocular disorders or diseases; Collagen for medical purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Diagnostic reagents for medicinal use; Medicinal preparations for ocular disorders or diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Veterinary diagnostic reagentsACTIVEJul 16, 2021

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 25, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 24, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 22, 2022SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 21, 2022CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 20, 2022SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 15, 2022IUAFUSE AMENDMENT FILED—
Apr 15, 2022EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 23, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 22, 2021EX5GSOU EXTENSION 5 GRANTED—
Oct 22, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 14, 2021EXT5SOU EXTENSION 5 FILED—
Oct 14, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 14, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 12, 2021EX4GSOU EXTENSION 4 GRANTED—
Apr 12, 2021EXT4SOU EXTENSION 4 FILED—
Apr 12, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 16, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 14, 2020EX3GSOU EXTENSION 3 GRANTED—
Oct 14, 2020EXT3SOU EXTENSION 3 FILED—
Oct 14, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 15, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 13, 2020EX2GSOU EXTENSION 2 GRANTED—
Apr 13, 2020EXT2SOU EXTENSION 2 FILED—
Apr 13, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 17, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 15, 2019EX1GSOU EXTENSION 1 GRANTED—
Oct 15, 2019EXT1SOU EXTENSION 1 FILED—
Oct 15, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 16, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 19, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 19, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 30, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 11, 2019ALIEASSIGNED TO LIE—
Dec 17, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 17, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Dec 17, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 17, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 17, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 13, 2018DOCKASSIGNED TO EXAMINER—
Sep 8, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 3, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance